Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

BATS BZX Real-Time Price
As of 12:04pm ET
 +1.84 / +1.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 190.00, with a high estimate of 250.00 and a low estimate of 93.00. The median estimate represents a +3.18% increase from the last price of 184.14.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Hold stock in Alnylam Pharmaceuticals Inc. This rating has held steady since August, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.26%
Growthannually 15.37%


Growthquarterly -0.71%
Growthannually 73.21%
Key to the earnings and sales forecast charts.